Global Hurthle Cell Carcinoma Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: G97681497A3FEN
QYResearch

Abstracts

This report focuses on the global Hurthle Cell Carcinoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hurthle Cell Carcinoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Smith & Nephew
• Pfizer
• EISAI
• Sanofi-Aventis
• Sun Pharmaceuticals
• Cadila Healthcare

Market segment by Type, the product can be split into

• General Surgery
• Total Thyroidectomy
• Robotic Surgery
• Radioactive Iodine (RAI)
• Others

Market segment by Application, split into

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Hurthle Cell Carcinoma Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Hurthle Cell Carcinoma Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hurthle Cell Carcinoma Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hurthle Cell Carcinoma Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Hurthle Cell Carcinoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 General Surgery
  1.4.3 Total Thyroidectomy
  1.4.4 Robotic Surgery
  1.4.5 Radioactive Iodine (RAI)
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Hurthle Cell Carcinoma Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Ambulatory Surgical Centers
  1.5.4 Clinics
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Hurthle Cell Carcinoma Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Hurthle Cell Carcinoma Treatment Industry
    1.6.1.1 Hurthle Cell Carcinoma Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Hurthle Cell Carcinoma Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Hurthle Cell Carcinoma Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Hurthle Cell Carcinoma Treatment Market Perspective (2015-2026)
2.2 Hurthle Cell Carcinoma Treatment Growth Trends by Regions
  2.2.1 Hurthle Cell Carcinoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hurthle Cell Carcinoma Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Hurthle Cell Carcinoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Hurthle Cell Carcinoma Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Hurthle Cell Carcinoma Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hurthle Cell Carcinoma Treatment Players by Market Size
  3.1.1 Global Top Hurthle Cell Carcinoma Treatment Players by Revenue (2015-2020)
  3.1.2 Global Hurthle Cell Carcinoma Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Hurthle Cell Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hurthle Cell Carcinoma Treatment Market Concentration Ratio
  3.2.1 Global Hurthle Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Hurthle Cell Carcinoma Treatment Revenue in 2019
3.3 Hurthle Cell Carcinoma Treatment Key Players Head office and Area Served
3.4 Key Players Hurthle Cell Carcinoma Treatment Product Solution and Service
3.5 Date of Enter into Hurthle Cell Carcinoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hurthle Cell Carcinoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hurthle Cell Carcinoma Treatment Forecasted Market Size by Type (2021-2026)

5 HURTHLE CELL CARCINOMA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020)
5.2 Global Hurthle Cell Carcinoma Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Hurthle Cell Carcinoma Treatment Market Size (2015-2020)
6.2 Hurthle Cell Carcinoma Treatment Key Players in North America (2019-2020)
6.3 North America Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020)
6.4 North America Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Hurthle Cell Carcinoma Treatment Market Size (2015-2020)
7.2 Hurthle Cell Carcinoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020)
7.4 Europe Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Hurthle Cell Carcinoma Treatment Market Size (2015-2020)
8.2 Hurthle Cell Carcinoma Treatment Key Players in China (2019-2020)
8.3 China Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020)
8.4 China Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Hurthle Cell Carcinoma Treatment Market Size (2015-2020)
9.2 Hurthle Cell Carcinoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020)
9.4 Japan Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Hurthle Cell Carcinoma Treatment Market Size (2015-2020)
10.2 Hurthle Cell Carcinoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Hurthle Cell Carcinoma Treatment Market Size (2015-2020)
11.2 Hurthle Cell Carcinoma Treatment Key Players in India (2019-2020)
11.3 India Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020)
11.4 India Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Hurthle Cell Carcinoma Treatment Market Size (2015-2020)
12.2 Hurthle Cell Carcinoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Smith & Nephew
  13.1.1 Smith & Nephew Company Details
  13.1.2 Smith & Nephew Business Overview and Its Total Revenue
  13.1.3 Smith & Nephew Hurthle Cell Carcinoma Treatment Introduction
  13.1.4 Smith & Nephew Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020))
  13.1.5 Smith & Nephew Recent Development
13.2 Pfizer
  13.2.1 Pfizer Company Details
  13.2.2 Pfizer Business Overview and Its Total Revenue
  13.2.3 Pfizer Hurthle Cell Carcinoma Treatment Introduction
  13.2.4 Pfizer Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020)
  13.2.5 Pfizer Recent Development
13.3 EISAI
  13.3.1 EISAI Company Details
  13.3.2 EISAI Business Overview and Its Total Revenue
  13.3.3 EISAI Hurthle Cell Carcinoma Treatment Introduction
  13.3.4 EISAI Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020)
  13.3.5 EISAI Recent Development
13.4 Sanofi-Aventis
  13.4.1 Sanofi-Aventis Company Details
  13.4.2 Sanofi-Aventis Business Overview and Its Total Revenue
  13.4.3 Sanofi-Aventis Hurthle Cell Carcinoma Treatment Introduction
  13.4.4 Sanofi-Aventis Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020)
  13.4.5 Sanofi-Aventis Recent Development
13.5 Sun Pharmaceuticals
  13.5.1 Sun Pharmaceuticals Company Details
  13.5.2 Sun Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Sun Pharmaceuticals Hurthle Cell Carcinoma Treatment Introduction
  13.5.4 Sun Pharmaceuticals Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020)
  13.5.5 Sun Pharmaceuticals Recent Development
13.6 Cadila Healthcare
  13.6.1 Cadila Healthcare Company Details
  13.6.2 Cadila Healthcare Business Overview and Its Total Revenue
  13.6.3 Cadila Healthcare Hurthle Cell Carcinoma Treatment Introduction
  13.6.4 Cadila Healthcare Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020)
  13.6.5 Cadila Healthcare Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Hurthle Cell Carcinoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hurthle Cell Carcinoma Treatment Revenue
Table 3. Ranking of Global Top Hurthle Cell Carcinoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hurthle Cell Carcinoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of General Surgery
Table 6. Key Players of Total Thyroidectomy
Table 7. Key Players of Robotic Surgery
Table 8. Key Players of Radioactive Iodine (RAI)
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Hurthle Cell Carcinoma Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Hurthle Cell Carcinoma Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Hurthle Cell Carcinoma Treatment Players to Combat Covid-19 Impact
Table 15. Global Hurthle Cell Carcinoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Hurthle Cell Carcinoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Hurthle Cell Carcinoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Hurthle Cell Carcinoma Treatment Market Share by Regions (2015-2020)
Table 19. Global Hurthle Cell Carcinoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Hurthle Cell Carcinoma Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Hurthle Cell Carcinoma Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Hurthle Cell Carcinoma Treatment Players
Table 26. Global Hurthle Cell Carcinoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Hurthle Cell Carcinoma Treatment Market Share by Players (2015-2020)
Table 28. Global Top Hurthle Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hurthle Cell Carcinoma Treatment as of 2019)
Table 29. Global Hurthle Cell Carcinoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Hurthle Cell Carcinoma Treatment Product Solution and Service
Table 32. Date of Enter into Hurthle Cell Carcinoma Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Hurthle Cell Carcinoma Treatment Market Size Share by Type (2015-2020)
Table 36. Global Hurthle Cell Carcinoma Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Hurthle Cell Carcinoma Treatment Market Size Share by Application (2015-2020)
Table 38. Global Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Hurthle Cell Carcinoma Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Hurthle Cell Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Hurthle Cell Carcinoma Treatment Market Share (2019-2020)
Table 42. North America Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Hurthle Cell Carcinoma Treatment Market Share by Type (2015-2020)
Table 44. North America Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Hurthle Cell Carcinoma Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Hurthle Cell Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Hurthle Cell Carcinoma Treatment Market Share (2019-2020)
Table 48. Europe Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Hurthle Cell Carcinoma Treatment Market Share by Type (2015-2020)
Table 50. Europe Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Hurthle Cell Carcinoma Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Hurthle Cell Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Hurthle Cell Carcinoma Treatment Market Share (2019-2020)
Table 54. China Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Hurthle Cell Carcinoma Treatment Market Share by Type (2015-2020)
Table 56. China Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Hurthle Cell Carcinoma Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Hurthle Cell Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Hurthle Cell Carcinoma Treatment Market Share (2019-2020)
Table 60. Japan Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Hurthle Cell Carcinoma Treatment Market Share by Type (2015-2020)
Table 62. Japan Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Hurthle Cell Carcinoma Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Hurthle Cell Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Hurthle Cell Carcinoma Treatment Market Share (2019-2020)
Table 66. Southeast Asia Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Hurthle Cell Carcinoma Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Hurthle Cell Carcinoma Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Hurthle Cell Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Hurthle Cell Carcinoma Treatment Market Share (2019-2020)
Table 72. India Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Hurthle Cell Carcinoma Treatment Market Share by Type (2015-2020)
Table 74. India Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Hurthle Cell Carcinoma Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Hurthle Cell Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Hurthle Cell Carcinoma Treatment Market Share (2019-2020)
Table 78. Central & South America Hurthle Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Hurthle Cell Carcinoma Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Hurthle Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Hurthle Cell Carcinoma Treatment Market Share by Application (2015-2020)
Table 82. Smith & Nephew Company Details
Table 83. Smith & Nephew Business Overview
Table 84. Smith & Nephew Product
Table 85. Smith & Nephew Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020) (Million US$)
Table 86. Smith & Nephew Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Product
Table 90. Pfizer Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020) (Million US$)
Table 91. Pfizer Recent Development
Table 92. EISAI Company Details
Table 93. EISAI Business Overview
Table 94. EISAI Product
Table 95. EISAI Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020) (Million US$)
Table 96. EISAI Recent Development
Table 97. Sanofi-Aventis Company Details
Table 98. Sanofi-Aventis Business Overview
Table 99. Sanofi-Aventis Product
Table 100. Sanofi-Aventis Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020) (Million US$)
Table 101. Sanofi-Aventis Recent Development
Table 102. Sun Pharmaceuticals Company Details
Table 103. Sun Pharmaceuticals Business Overview
Table 104. Sun Pharmaceuticals Product
Table 105. Sun Pharmaceuticals Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020) (Million US$)
Table 106. Sun Pharmaceuticals Recent Development
Table 107. Cadila Healthcare Company Details
Table 108. Cadila Healthcare Business Overview
Table 109. Cadila Healthcare Product
Table 110. Cadila Healthcare Revenue in Hurthle Cell Carcinoma Treatment Business (2015-2020) (Million US$)
Table 111. Cadila Healthcare Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hurthle Cell Carcinoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. General Surgery Features
Figure 3. Total Thyroidectomy Features
Figure 4. Robotic Surgery Features
Figure 5. Radioactive Iodine (RAI) Features
Figure 6. Others Features
Figure 7. Global Hurthle Cell Carcinoma Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Hurthle Cell Carcinoma Treatment Report Years Considered
Figure 13. Global Hurthle Cell Carcinoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Hurthle Cell Carcinoma Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Hurthle Cell Carcinoma Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Hurthle Cell Carcinoma Treatment Market Share by Players in 2019
Figure 18. Global Top Hurthle Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hurthle Cell Carcinoma Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Hurthle Cell Carcinoma Treatment Revenue in 2019
Figure 20. North America Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Hurthle Cell Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Smith & Nephew Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Smith & Nephew Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2015-2020)
Figure 31. EISAI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. EISAI Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2015-2020)
Figure 33. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sanofi-Aventis Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2015-2020)
Figure 35. Sun Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sun Pharmaceuticals Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2015-2020)
Figure 37. Cadila Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Cadila Healthcare Revenue Growth Rate in Hurthle Cell Carcinoma Treatment Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed